Immunotherapy of inflammatory bowel diseases: Current concepts and future perspectives

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 2, 2000, Pages 81-84

  Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Crohn's disease; Cytokines; Gene transfer; Immunotherapy; Ulcerative colitis

Indexed keywords

CYTOKINE;

ANIMAL; CROHN DISEASE; DISEASE MODEL; ENTERITIS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MOUSE; RAT; REVIEW; T LYMPHOCYTE SUBPOPULATION; ULCERATIVE COLITIS;

ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOTHERAPY; INFLAMMATORY BOWEL DISEASES; MICE; RATS; T-LYMPHOCYTE SUBSETS;

EID: 0033660854     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. AUTSCHBACH F., SCHURMANN G., QIAO L., MERZ H. et al. (1995): Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease. Virchows Arch., 426, 51.
2. + T lymphocytes. J. Immunol., 160, 3642.
3. BOIRIVANT M., FUSS I. J., CHU A. and STROBER W. (1998): Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med., 188, 1929.
4. BREESE E., BRAEGGER C. P., CORRIGAN C. J., WALKER-SMITH J. A. and MACDONALD T. T. (1993): Interleukin-2 and interferon-γ secreting T cells in normal and diseased human intestinal mucosa. Immunology, 78, 127.
5. BREESE E. and MACDONALD T. T. (1996) TNF-α secreting cells in normal and diseased human intestine. Adv. Exp. Med. Biol., 371B, 821.
6. CHRIST A., STEVENS A., KOEPPEN H., WALSH S. et al. (1998): An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease. Gastroenterology, 115, 307.
7. DEVENTER S. V., ELSON C. and FEDORAK R. (1997): Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Gastroenterology, 113, 383.
8. D'HAENS G., GEBOES K., PEETERS M. and BAERT F. (1998): Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology, 114, 262.
9. DONALDSON R. (1989): Crohn's disease. In: SLEISENGER M. and FORDTRAN J.: Gastrointestinal disease. W. B. Saunders Corp., Philadelpia, 1327.
10. DUCHMANN R. and ZEITZ M. (1999): Crohn's disease. In: OGRA P. and STROBER W. (eds.): Handbook of mucosal immunology. Academic Press, New York, 1055.
11. DULLEMEN H. v., DEVENTER S. v., HOMMES D., BIJL H. et al. (1995): Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology, 109, 129.
12. ELSON C. O., SARTOR R. B., TENNYSON G. S. and RIDDELL R. H. (1995): Experimental models of inflammatory bowel disease. Gastroenterology, 109, 1344.
13. + lamina propria (LP) lymphocyte secretion profiles in inflammatory bowel disease. J. Immunol., 157, 1261.
14. KORNBLUTH A., SALOMON P. and SACHAR D. B. (1995): Crohn's disease. In FORDTRAN J. and SLEISINGER M. (eds.): Gastrointestinal disease. Pathophysiology, diagnosis, management. W. B. Saunders Corp., Philadelphia, 1270.
15. KÜHN R., LÖHLER J., RENNICK D., RAJEWSKY K. and MÜLLER W. (1993): Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 75, 263.
16. MIZOGUCHI A., MIZOGUCHI E. and BHAN A. K. (1999): The critical role of interleukin 4 but not interferon γ in the pathogen-esis of colitis in T-cell receptor α mutant mice. Gastroenterology, 116, 320.
17. MONTELEONE G., BIANCONE L., MARASCO R., MORRONE G. et al. (1997): Interleukin-12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology, 112, 1169.
18. NEURATH M. F., FUSS I., KELSALL B. L., PRESKY D. H. et al. (1996): Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med., 183, 2515.
19. NEURATH M. F., FUSS I., KELSALL B. L., STUBER E. and STROBER W. (1995): Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med., 182, 1280.
20. NEURATH M. F., PETTERSSON S., BUSCHENFELDE K. H. M. z, and STROBER W. (1996): Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat. Med., 2, 998.
21. PIZARRO T. T., MICHIE M. H., BENTZ M., WORARATANADHARM J. et al. (1999): IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol., 162, 6829.
22. PLEVY S. E., LANDERS C. J., PREHN J., CARRAMANZANA N. M. et al. (1997): A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol., 159, 6276.
23. PODOLSKY D. K. (1991): Inflammatory bowel disease. N. Engl. J. Med., 325, 928.
24. + T cells. J. Exp. Med., 183, 2669.
25. + T cells. Immunity, 2, 553.
26. + αβ T cells in the colonie lamina propria of seid mice with colitis. Eur. J. Immunol., 26, 1156.
27. SARTOR R. (1998): Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream. Gastroenterology, 114, 398.
28. STROBER W. and NEURATH M. F. (1995): Chapter 94. Immunological diseases of the gastrointestinal tract. In RICH R. R. (ed.): Clinical immunology. Mosby, St. Louis, 1401.
29. TARGAN S. R., HANAUER S. B., DEVENTER S. J. V., MAYER L. et al. (1997): A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N. Engl. J. Med., 337, 1029.
30. + T cells that respond to bacterial antigens. J. Immunol., 162, 1884.
31. WIRTZ S., GALLE P. and NEURATH M. (1999): Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure. Gut, 44, 800.